Browsing byAuthorPazderka, C
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
2015-06-01 | Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs | Murray, M; Hraiki, A; Bebawy, M; Pazderka, C; Rawling, T |
- | Aryl urea substituted fatty acids: a new class of protonophoric mitochondrial uncoupler that utilises a synthetic anion transporter | Rawling, T; MacDermott-Opeskin, H; Roseblade, A; Pazderka, C; Clarke, C; Bourget, K; Wu, X; Lewis, W; Noble, B; Gale, PA; O'Mara, ML; Cranfield, C; Murray, M |
2019-03-01 | Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells | Al-Zubaidi, Y; Pazderka, C; Koolaji, N; Rahman, MK; Choucair, H; Umashankar, B; Bourget, K; Chen, Y; Rawling, T; Murray, M |
2023-01-15 | Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acids. | Rahman, MK; Umashankar, B; Choucair, H; Pazderka, C; Bourget, K; Chen, Y; Dunstan, CR; Rawling, T; Murray, M |
2018-10-13 | Nanoemulsion-enabled oral delivery of novel anticancer ω-3 fatty acid derivatives | Pereira, GG; Rawling, T; Pozzoli, M; Pazderka, C; Chen, Y; Dunstan, CR; Murray, M; Sonvico, F |